ÂÜÀòÂÒÂ×

Head of the Clinic of Gastroenterology at University Hospital Zurich with over 25 years of clinical experience, Gerhard Rogler is a world renowned expert in his field. Gerhard heads the Swiss Inflammatory Bowel Disease (IBD) cohort, is a member of the International Organization of IBD Research (IOIBD) and sits on the Governing Board of the European Crohn’s and Colitis Organization (ECCO). He has published over 450 scientific articles and actively performs Fecal Microbiota Transplantation (FMT) as a therapy for recurrent Clostridium difficile Infection (rCDI). Gerhard is an experienced medical advisor to pharmaceutical companies with a clear understanding of market needs. As a member of the board, he supports a fast and patient-oriented implementation of PharmaBiome’s developments.